125 related articles for article (PubMed ID: 35485853)
21. Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities.
Hirmas N; Hamacher R; Sraieb M; Ingenwerth M; Kessler L; Pabst KM; Barbato F; Lueckerath K; Kasper S; Nader M; Schildhaus HU; Kesch C; von Tresckow B; Hanoun C; Hautzel H; Aigner C; Glas M; Stuschke M; Kümmel S; Harter P; Lugnier C; Uhl W; Niedergethmann M; Hadaschik B; Grünwald V; Siveke JT; Herrmann K; Fendler WP
J Nucl Med; 2023 May; 64(5):711-716. PubMed ID: 36581374
[TBL] [Abstract][Full Text] [Related]
22. [
Hu K; Wang L; Wu H; Huang S; Tian Y; Wang Q; Xiao C; Han Y; Tang G
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2833-2843. PubMed ID: 34893920
[TBL] [Abstract][Full Text] [Related]
23. Comparison of 68 Ga-FAPI-04 and fluorine-18-fluorodeoxyglucose PET/computed tomography in the detection of ovarian malignancies.
Zheng W; Liu L; Feng Y; Wang L; Chen Y
Nucl Med Commun; 2023 Mar; 44(3):194-203. PubMed ID: 36472415
[TBL] [Abstract][Full Text] [Related]
24. Comparison of
Sayiner ZA; Elboğa U; Sahin E; Ozturk S; Cayirli YB; Celen YZ; Akarsu E; Dogan I; Kilbas B; Eryilmaz K; Cakici D
Hell J Nucl Med; 2023; 26(1):41-46. PubMed ID: 37115220
[TBL] [Abstract][Full Text] [Related]
25. [
Huang D; Wu J; Zhong H; Li Y; Han Y; He Y; Chen Y; Lin S; Pang H
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):908-920. PubMed ID: 36326867
[TBL] [Abstract][Full Text] [Related]
26. Value of [
Zhou Y; Yang X; Liu H; Luo W; Liu H; Lv T; Wang J; Qin J; Ou S; Chen Y
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3493-3501. PubMed ID: 33829416
[TBL] [Abstract][Full Text] [Related]
27. Superiority of [
Fu L; Huang S; Wu H; Dong Y; Xie F; Wu R; Zhou K; Tang G; Zhou W
Eur Radiol; 2022 Sep; 32(9):6281-6290. PubMed ID: 35380229
[TBL] [Abstract][Full Text] [Related]
28. The potential utility of [
Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
[TBL] [Abstract][Full Text] [Related]
29. Accurate preoperative staging with [
Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of preoperative [
Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic performance of Ga-68 FAPI 04 PET/CT in colorectal malignancies.
Prashanth A; Kumar Ravichander S; Eswaran P; Kalyan S; Maheswari Babu S
Nucl Med Commun; 2023 Apr; 44(4):276-283. PubMed ID: 36756771
[TBL] [Abstract][Full Text] [Related]
32. Clinical Evaluation of
Zhao L; Wen X; Xu W; Pang Y; Sun L; Wu X; Xu P; Zhang J; Guo Z; Lin Q; Chen X; Chen H
J Nucl Med; 2023 Aug; 64(8):1210-1217. PubMed ID: 37142301
[TBL] [Abstract][Full Text] [Related]
33. 68 Ga-FAPI-04 Versus 18 F-FDG PET/CT in Detection of Epithelioid Malignant Pleural Mesothelioma.
Dong A; Zhao B; Cheng C; Zuo C
Clin Nucl Med; 2022 Nov; 47(11):980-981. PubMed ID: 36215397
[TBL] [Abstract][Full Text] [Related]
34. Head-to-Head Comparison of
Promteangtrong C; Siripongsatian D; Jantarato A; Kunawudhi A; Kiatkittikul P; Yaset S; Boonkawin N; Chotipanich C
J Nucl Med; 2022 Aug; 63(8):1155-1161. PubMed ID: 34857655
[No Abstract] [Full Text] [Related]
35.
Luo Y; Pan Q; Zhou Z; Li M; Wei Y; Jiang X; Yang H; Li F
Radiology; 2023 May; 307(3):e222052. PubMed ID: 36853178
[TBL] [Abstract][Full Text] [Related]
36. Head-to-head comparison of [
Liu S; Feng Z; Xu X; Ge H; Ju X; Wu X; Song S
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1521-1531. PubMed ID: 36624168
[TBL] [Abstract][Full Text] [Related]
37. Dual targeting PET tracer [
Wang R; Jakobsson V; Wang J; Zhao T; Peng X; Li B; Xue J; Liang N; Zhu Z; Chen X; Zhang J
Theranostics; 2023; 13(9):2979-2992. PubMed ID: 37284441
[No Abstract] [Full Text] [Related]
38. [
Rosenkrans ZT; Massey CF; Bernau K; Ferreira CA; Jeffery JJ; Schulte JJ; Moore M; Valla F; Batterton JM; Drake CR; McMillan AB; Sandbo N; Pirasteh A; Hernandez R
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3705-3716. PubMed ID: 35556159
[TBL] [Abstract][Full Text] [Related]
39. Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [
Siripongsatian D; Promteangtrong C; Kunawudhi A; Kiatkittikul P; Boonkawin N; Chinnanthachai C; Jantarato A; Chotipanich C
Mol Imaging Biol; 2022 Oct; 24(5):818-829. PubMed ID: 35486293
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the role of 18 F-fluorodeoxyglucose PET/computed tomography and 68 Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma.
Güzel Y; Kömek H; Can C; Kaplan İ; Kepenek F; Ebinç S; Büyükdeniz MP; Gündoğan C; Oruç Z
Nucl Med Commun; 2023 Jul; 44(7):631-639. PubMed ID: 37114422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
